GGTLC1 | Gamma-glutamyltransferase light chain 1 | | | | | | Group enriched |
IQCD | IQ motif containing D | | | | | | Group enriched |
LECT1 | Leukocyte cell derived chemotaxin 1 | Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
LRRTM3 | Leucine rich repeat transmembrane neuronal 3 | Predicted membrane proteins
| | | | | Group enriched |
NAT8L | N-acetyltransferase 8-like (GCN5-related, putative) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Group enriched |
PABPC1L2A | Poly(A) binding protein, cytoplasmic 1-like 2A | | | | | | Group enriched |
RIBC2 | RIB43A domain with coiled-coils 2 | | | | | | Group enriched |
SEC14L4 | SEC14-like 4 (S. cerevisiae) | | | | | | Group enriched |
TCTE1 | T-complex-associated-testis-expressed 1 | | | | | | Group enriched |
TGM7 | Transglutaminase 7 | Cancer-related genes Enzymes Plasma proteins
| | | | | Group enriched |
ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
ARMC3 | Armadillo repeat containing 3 | | | | | | Group enriched |
C9orf171 | Chromosome 9 open reading frame 171 | | | | | | Group enriched |
CHRNB4 | Cholinergic receptor, nicotinic, beta 4 (neuronal) | FDA approved drug targets Predicted membrane proteins
| | | | | Group enriched |
DLGAP2 | Discs, large (Drosophila) homolog-associated protein 2 | Nuclear receptors
| | | | | Group enriched |
DNAAF1 | Dynein, axonemal, assembly factor 1 | Disease related genes
| | | | | Group enriched |
DRC1 | Dynein regulatory complex subunit 1 homolog (Chlamydomonas) | Cytoskeleton related proteins Disease related genes
| | | | | Group enriched |
FABP12 | Fatty acid binding protein 12 | | | | | | Group enriched |
LHX9 | LIM homeobox 9 | Transcription factors
| | | | | Group enriched |
MDGA2 | MAM domain containing glycosylphosphatidylinositol anchor 2 | Predicted membrane proteins
| | | | | Group enriched |
MEGF11 | Multiple EGF-like-domains 11 | Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
PABPC1L2B | Poly(A) binding protein, cytoplasmic 1-like 2B | | | | | | Group enriched |
PHOSPHO1 | Phosphatase, orphan 1 | Enzymes
| | | | | Group enriched |
PPP1R42 | Protein phosphatase 1, regulatory subunit 42 | | | | | | Group enriched |
RSPH10B | Radial spoke head 10 homolog B (Chlamydomonas) | | | | | | Group enriched |
RSPH10B2 | Radial spoke head 10 homolog B2 (Chlamydomonas) | | | | | | Group enriched |
SLC22A16 | Solute carrier family 22 (organic cation/carnitine transporter), member 16 | Predicted membrane proteins
| | | | | Group enriched |
SLC6A2 | Solute carrier family 6 (neurotransmitter transporter), member 2 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Group enriched |
SPAG6 | Sperm associated antigen 6 | | | | | | Group enriched |
TMEM130 | Transmembrane protein 130 | Predicted membrane proteins
| | | | | Group enriched |
TSNAXIP1 | Translin-associated factor X interacting protein 1 | | | | | | Group enriched |
ARMS2 | Age-related maculopathy susceptibility 2 | Disease related genes Mitochondrial proteins
| | | | | Group enriched |
C10orf90 | Chromosome 10 open reading frame 90 | | | | | | Group enriched |
C14orf23 | Chromosome 14 open reading frame 23 | | | | | | Group enriched |
C5orf49 | Chromosome 5 open reading frame 49 | | | | | | Group enriched |
C9orf116 | Chromosome 9 open reading frame 116 | | | | | | Group enriched |
C9orf135 | Chromosome 9 open reading frame 135 | | | | | | Group enriched |
CCDC65 | Coiled-coil domain containing 65 | Disease related genes
| | | | | Group enriched |
CHRM5 | Cholinergic receptor, muscarinic 5 | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Group enriched |
CNGA4 | Cyclic nucleotide gated channel alpha 4 | Predicted membrane proteins Voltage-gated ion channels
| | | | | Group enriched |
COL20A1 | Collagen, type XX, alpha 1 | Predicted secreted proteins
| | | | | Group enriched |
FBLL1 | Fibrillarin-like 1 | | | | | | Group enriched |
IFLTD1 | Intermediate filament tail domain containing 1 | Predicted secreted proteins
| | | | | Group enriched |
LRRC18 | Leucine rich repeat containing 18 | | | | | | Group enriched |
LRRC46 | Leucine rich repeat containing 46 | | | | | | Group enriched |
MLF1 | Myeloid leukemia factor 1 | Cancer-related genes Disease related genes
| | | | | Group enriched |
NME8 | NME/NM23 family member 8 | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
OLAH | Oleoyl-ACP hydrolase | Enzymes
| | | | | Group enriched |
PENK | Proenkephalin | Plasma proteins Predicted secreted proteins Transporters
| | | | | Group enriched |
REG3G | Regenerating islet-derived 3 gamma | Predicted secreted proteins
| | | | | Group enriched |